Personal information

No personal information available

Activities

Employment (2)

Dana-Farber Cancer Institute: Boston, Massachusetts, US

2021-07-01 to present | Clinical Fellow in Hematology and Oncology
Employment
Source: Self-asserted source
Alexander C. Jordan

New York University Grossman School of Medicine: New York, NY, US

2017-07-01 to 2021-06-30 | Resident Physician
Employment
Source: Self-asserted source
Alexander C. Jordan

Education and qualifications (3)

University of Pennsylvania Perelman School of Medicine: Philadelphia, PA, US

2013-08 to 2017-05-14 | Doctor of Medicine
Education
Source: Self-asserted source
Alexander C. Jordan

Massachusetts Institute of Technology: Cambridge, MA, US

2009-09 to 2013-06 | Bachelor of Science (Biology)
Education
Source: Self-asserted source
Alexander C. Jordan

Winter Park High School: Winter Park, FL, US

2006-08 to 2009-05 | High School Diploma
Education
Source: Self-asserted source
Alexander C. Jordan

Professional activities (1)

American Society of Clinical Oncology: Alexandria, Virginia, US

Membership
Source: Self-asserted source
Alexander C. Jordan

Works (19)

Data from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

Cancer Discovery
2024-11-01 | Journal article
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Figures 1-11 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 1 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 2 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 3 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 4 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 5 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 6 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 7 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 8 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Supplemental Table 9 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

2024-11-01 | Preprint
Contributors: Julien Dilly; Megan T. Hoffman; Laleh Abbassi; Ziyue Li; Francesca Paradiso; Brendan D. Parent; Connor J. Hennessey; Alexander C. Jordan; Micaela Morgado; Shatavisha Dasgupta et al.
Source: check_circle
Crossref

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

Cancers
2022-12-16 | Journal article
Part of ISSN: 2072-6694
Contributors: Brandon Huffman; Haley Ellis; Alexander C. Jordan; William A. Freed-Pastor; Kimberly Perez; Douglas Rubinson; Nilay Sethi; Harshabad Singh; Rishi Surana; Brian M. Wolpin et al.
Source: Self-asserted source
Alexander C. Jordan

COVID‐19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system

Cancer
2021-09-15 | Journal article
Part of ISSN: 0008-543X
Part of ISSN: 1097-0142
Contributors: Alexander C. Jordan
Source: Self-asserted source
Alexander C. Jordan

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer

Molecular Therapy
2020-11 | Journal article
Part of ISSN: 1525-0016
Contributors: Alexander C. Jordan
Source: Self-asserted source
Alexander C. Jordan

Immunotherapy in hepatocellular carcinoma: Combination strategies

World Journal of Meta-Analysis
2020-06-28 | Journal article
Part of ISSN: 2308-3840
Contributors: Alexander C. Jordan
Source: Self-asserted source
Alexander C. Jordan

Oxidative phosphorylation promotes primary melanoma invasion

The American Journal of Pathology
2020-03 | Journal article
Part of ISSN: 0002-9440
Source: Self-asserted source
Alexander C. Jordan
grade
Preferred source (of 2)‎

Peripheral Blood T-Cell Fitness Is Diminished in Patients With Pancreatic Carcinoma but Can Be Improved With Homeostatic Cytokines

Cellular and Molecular Gastroenterology and Hepatology
2019 | Journal article
Part of ISSN: 2352-345X
Contributors: Alexander C. Jordan
Source: Self-asserted source
Alexander C. Jordan

A diverse array of cancer-associated mTOR mutations are hyperactivating and can predict rapamycin sensitivity

2014 | Other
Contributors: Grabiner, Brian C.; Nardi, Valentina; Birsoy, Kivanc; Possemato, Richard; Shen, Kuang; Sinha, Sumi; Jordan, Alexander; Beck, Andrew H.; Sabatini, David M.
Source: Self-asserted source
Alexander C. Jordan via BASE - Bielefeld Academic Search Engine